Literature DB >> 141300

Electrical stimulation in chronic low-back pain.

B Rutkowski, T Niedzialkowska, J Otto.   

Abstract

Since 1972, 367 patients with chronic low-back pain have been treated by electrical stimulation (e.s.). Patients with herniated disc lesions and spondylitis and allied conditions were included. Following e.s. 75-100% pain relief was obtained by 53% of the patients 50% pain relief by 27% and there was no improvement in 20% of patients. In a follow-up of 208 patients, 6-36 months later, approximately 70% stated that pain relief was similar to that obtained at the end of treatment.

Entities:  

Mesh:

Year:  1977        PMID: 141300     DOI: 10.1093/bja/49.6.629

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Transcutaneous electrical nerve stimulation for relief of pain of venopuncture.

Authors:  T Tsubaki; K Aono; A Tamesue; T Nakajima; H Himuro; T Murata
Journal:  J Anesth       Date:  1990-01       Impact factor: 2.078

2.  Effects of therapeutic ultrasound and electrical stimulation program on pain, trunk muscle strength, disability, walking performance, quality of life, and depression in patients with low back pain: a randomized-controlled trial.

Authors:  Dilek Durmus; Yunus Durmaz; Ferhan Canturk
Journal:  Rheumatol Int       Date:  2009-07-31       Impact factor: 2.631

Review 3.  Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain.

Authors:  Amole Khadilkar; Daniel Oluwafemi Odebiyi; Lucie Brosseau; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 4.  Peripheral neuromodulation: a review.

Authors:  Teodor Goroszeniuk; David Pang
Journal:  Curr Pain Headache Rep       Date:  2014-05

5.  Effects of electrical stimulation program on trunk muscle strength, functional capacity, quality of life, and depression in the patients with low back pain: a randomized controlled trial.

Authors:  Dilek Durmus; Yesim Akyol; Gamze Alayli; Berna Tander; Yeliz Zahiroglu; Ferhan Canturk
Journal:  Rheumatol Int       Date:  2008-12-20       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.